Natixis Bleichroeder Upgrades Invacare (IVC) to Buy in Intraday Report
Natixis Bleichroeder has upgraded shares of Invacare (NYSE: IVC) from Hold to Buy today, citing increase confidence that the company is "gaining sales momentum, executing, and could deliver potential upside in 2010." The firm maintains a $29 price target. Today's research note from Natixis follows Q2 results from Invacare this morning. The...
Get Alerted When News Hits On This Stock - FREE!